Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells

被引:626
作者
Cowan, CA [1 ]
Atienza, J [1 ]
Melton, DA [1 ]
Eggan, K [1 ]
机构
[1] Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
关键词
D O I
10.1126/science.1116447
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We have explored the use of embryonic stem cells as an alternative to oocytes for reprogramming human somatic nuclei. Human embryonic stem (hES) cells were fused with human fibroblasts, resulting in hybrid cells that maintain a stable tetraploid DNA content and have morphology, growth rate, and antigen expression patterns characteristic of hES cells. Differentiation of hybrid cells in vitro and in vivo yielded cell types from each embryonic germ layer. Analysis of genome-wide transcriptional activity, reporter gene activation, allele-specific gene expression, and DNA methylation showed that the somatic genome was reprogrammed to an embryonic state. These results establish that hES cells can reprogram the transcriptional state of somatic nuclei and provide a system for investigating the underlying mechanisms.
引用
收藏
页码:1369 / 1373
页数:5
相关论文
共 28 条
[1]   Unique gene expression signatures of independently-derived human embryonic stem cell lines [J].
Abeyta, MJ ;
Clark, AT ;
Rodriguez, RT ;
Bodnar, MS ;
Pera, RAR ;
Firpo, MT .
HUMAN MOLECULAR GENETICS, 2004, 13 (06) :601-608
[2]   3 MONOCLONAL-ANTIBODIES DEFINING DISTINCT DIFFERENTIATION ANTIGENS ASSOCIATED WITH DIFFERENT HIGH MOLECULAR-WEIGHT POLYPEPTIDES ON THE SURFACE OF HUMAN EMBRYONAL CARCINOMA-CELLS [J].
ANDREWS, PW ;
BANTING, G ;
DAMJANOV, I ;
ARNAUD, D ;
AVNER, P .
HYBRIDOMA, 1984, 3 (04) :347-361
[3]   IMMUNOCHEMICAL ANALYSIS OF MYOSIN HEAVY-CHAIN DURING AVIAN MYOGENESIS INVIVO AND INVITRO [J].
BADER, D ;
MASAKI, T ;
FISCHMAN, DA .
JOURNAL OF CELL BIOLOGY, 1982, 95 (03) :763-770
[4]   Gene expression in human embryonic stem cell lines: unique molecular signature [J].
Bhattacharya, B ;
Miura, T ;
Brandenberger, R ;
Mejido, J ;
Luo, YQ ;
Yang, AX ;
Joshi, BH ;
Ginis, I ;
Thies, RS ;
Amit, M ;
Lyons, I ;
Condie, BG ;
Itskovitz-Eldor, J ;
Rao, MS ;
Puri, RK .
BLOOD, 2004, 103 (08) :2956-2964
[5]   Setting standards for human embryonic stem cells [J].
Brivanlou, AH ;
Gage, FH ;
Jaenisch, R ;
Jessell, T ;
Melton, D ;
Rossant, J .
SCIENCE, 2003, 300 (5621) :913-+
[6]   Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells [J].
Chambers, I ;
Colby, D ;
Robertson, M ;
Nichols, J ;
Lee, S ;
Tweedie, S ;
Smith, A .
CELL, 2003, 113 (05) :643-655
[7]  
Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330
[8]   Prospects for stem cell therapeutics: myths and medicines [J].
Daley, GQ .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2002, 12 (05) :607-613
[9]   Sequential DNA methylation of the Nanog and Oct-4 upstream regions in human NT2 cells during neuronal differentiation [J].
Deb-Rinker, P ;
Ly, D ;
Jezierski, A ;
Sikorska, M ;
Walker, PR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (08) :6257-6260
[10]   Nuclei of embryonic stem cells reprogram somatic cells [J].
Do, JT ;
Schöler, HR .
STEM CELLS, 2004, 22 (06) :941-949